Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Payments to Acquire Businesses, Net of Cash Acquired

Payments to Acquire Businesses, Net of Cash Acquired at other companies

US Foods logo
US FoodsUSFD
——

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: USANA Health Sciences’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's payments to acquire businesses, net of cash acquired.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's payments to acquire businesses, net of cash acquired?
USANA Health Sciences (USNA) reported payments to acquire businesses, net of cash acquired of $0 in Q4 2025.
How has USANA Health Sciences's payments to acquire businesses, net of cash acquired changed year-over-year?
USANA Health Sciences's payments to acquire businesses, net of cash acquired decreased by 100.0% year-over-year, from $50.83M to $0.
What does payments to acquire businesses, net of cash acquired mean?
The net cash outflow required to complete business acquisitions, calculated as the total purchase price minus the cash and cash equivalents held by the acquired entity. This metric is a primary indicator of the capital deployed for inorganic growth and expansion strategies.